Related Experiment Video
Updated: Oct 9, 2025

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Integrative Bioinformatics Analysis Revealed Mitochondrial Defects Underlying Hypoplastic Left Heart Syndrome
Diming Zhao1, Yilin Liu2, Zhenqiang Xu3,4
1Department of Cardiovascular Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.
Insights
This study reveals key mitochondrial genes and pathways involved in heart failure in hypoplastic left heart syndrome (HLHS). Findings offer insights into disease mechanisms and potential therapeutic targets for HLHS.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Bioinformatics
Background:
- Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect with poorly understood heart failure mechanisms.
- Identifying the molecular underpinnings of heart failure in HLHS is crucial for improving patient outcomes.
Purpose of the Study:
- To elucidate the genetic and molecular mechanisms driving heart failure in hypoplastic left heart syndrome (HLHS).
- To identify key genes, regulatory pathways, transcription factors (TFs), and microRNAs (miRNAs) associated with heart failure in HLHS.
Main Methods:
- Integrative bioinformatics analysis of microarray dataset GSE23959.
- Identification of differentially expressed genes (DEGs) and functional enrichment analysis (GO, KEGG).
- Construction and analysis of protein-protein interaction (PPI) networks and integrated TF-DEG and miRNA-DEG networks.
Main Results:
- 210 DEGs were identified, with enrichment analysis highlighting mitochondrial dysfunction.
- 15 hub genes, including NDUFB6 and ATP5H, were identified, emphasizing mitochondrial components and functions.
- Key TFs (e.g., NFKB1, RELA) and miRNAs (e.g., hsa-miR-155-5p) were detected, suggesting NF-κB pathway involvement.
Conclusions:
- Integrative bioinformatics analysis successfully identified mitochondrial-related factors in HLHS-associated heart failure.
- This study enhances understanding of HLHS pathogenesis and points to novel therapeutic targets.
- Mitochondrial dysfunction and associated regulatory networks are central to heart failure in HLHS.
Background:
Hypoplastic left heart syndrome (HLHS) is one of the most complex congenital cardiac malformations, and the molecular mechanism of heart failure (HF) in HLHS is still elusive.
Methods:
Integrative bioinformatics analysis was performed to unravel the underlying genes and mechanisms involved in HF in HLHS. Microarray dataset GSE23959 was screened out for the differentially expressed genes (DEGs), after which the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were carried out using the Metascape. The protein-protein interaction (PPI) network was generated, and the modules and hub genes were identified with the Cytoscape-plugin. And the integrated network of transcription factor (TF)-DEGs and miRNA-DEGs was constructed, respectively.
Results:
A total of 210 DEGs were identified, including 135 up-regulated and 75 down-regulated genes. The functional enrichment analysis of DEGs pointed towards the mitochondrial-related biological processes, cellular components, molecular functions and signaling pathways. A PPI network was constructed including 155 nodes as well as 363 edges. And 15 hub genes, such as NDUFB6, UQCRQ, SDHD, ATP5H, were identified based on three topological analysis methods and mitochondrial components and functions were the most relevant. Furthermore, by integrating network interaction construction, 23 TFs (NFKB1, RELA, HIF1A, VHL, GATA1, PPAR-γ, etc.) as well as several miRNAs (hsa-miR-155-5p, hsa-miR-191-5p, hsa-mir-124-3p, hsa-miR-1-3p, etc.) were detected and indicated the possible involvement of NF-κB signaling pathways in mitochondrial dysfunction in HLHS.
Conclusion:
The present study applied the integrative bioinformatics analysis and revealed the mitochondrial-related key genes, regulatory pathways, TFs and miRNAs underlying the HF in HLHS, which improved the understanding of disease mechanisms and the development of novel therapeutic targets.
Related Concept Videos
Animal Mitochondrial Genetics
Cardiomyopathy III: Hypertrophic Cardiomyopathy

